AHL Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-39,932
Closed -$572K 1258
2017
Q3
$572K Sell
39,932
-3,980
-9% -$60.2K 0.01% 1017
2017
Q2
$760K Buy
+43,912
New +$526K 0.02% 858
2016
Q1
Sell
-20,907
Closed -$2.13M 756
2015
Q4
$2.13M Buy
20,907
+18,160
+661% +$2.04M 0.16% 236
2015
Q3
$490K Sell
2,747
-9,808
-78% -$2.29M 0.08% 384
2015
Q2
$2.79M Sell
12,555
-13,508
-52% -$2.99M 0.11% 408
2015
Q1
$5.18M Buy
26,063
+9,048
+53% +$1.61M 0.21% 170
2014
Q4
$2.44M Buy
+17,015
New +$2.29M 0.13% 365

Other funds holding BHC

AHL Partners's BHC Position: Q4 2017 in Review

AHL Partners sold out of Bausch Health (BHC) in Q4 2017, closing a stake of 39,932 shares — an estimated $572K sold.

AHL Partners first reported a position in BHC in Q4 2014 and held it in 7 quarters. The position peaked at $5.18M in Q1 2015. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2017.

  • AHL Partners reported no remaining Bausch Health position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 39,932 Bausch Health shares in Q4 2017, an estimated $572K.
  • AHL Partners first reported a position in Bausch Health in Q4 2014 and held it in 7 quarters.
  • AHL Partners's Bausch Health position peaked at $5.18M in Q1 2015.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.